Proposed Collection; 60-Day Comment Request; Responsibility of Applicants for Promoting Objectivity in Research for Which Public Health Service (PHS) Funding Is Sought and Responsible Prospective Contractors, Office of Policy for Extramural Research Administration (OPERA), Office of Extramural Research (OER), Office of the Director, (OD), 11763-11765 [2018-05384]
Download as PDF
Federal Register / Vol. 83, No. 52 / Friday, March 16, 2018 / Notices
The prospective exclusive license will
be royalty bearing, and the prospective
exclusive license may be granted unless
within fifteen (15) days from the date of
this published notice, the National
Cancer Institute receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR part 404.
In response to this Notice, the public
may file comments or objections.
Comments and objections, other than
those in the form of a completed license
application, will not be treated
confidentially, and may be made
publicly available.
License applications submitted in
response to this Notice must be
complete and in acceptable form by the
expiration date of this Notice to be
considered for a license. License
applications submitted in response to
this Notice will be presumed to contain
business confidential information and
any release of information in these
license applications will be made only
as required and upon a request under
the Freedom of Information Act, 5
U.S.C. 552.
Dated: March 8, 2018.
Richard U. Rodriguez,
Associate Director, Technology Transfer
Center, National Cancer Institute.
[FR Doc. 2018–05310 Filed 3–15–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
daltland on DSKBBV9HB2PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: April 3, 2018.
Time: 1:00 p.m. to 5:00 p.m.
VerDate Sep<11>2014
21:54 Mar 15, 2018
Jkt 244001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Shalanda A Bynum, Ph.D.,
MPH, Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
Bethesda, MD 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: April 6, 2018.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Endocrinology, Metabolism,
Nutrition, and Reproductive Science.
Date: April 6, 2018.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
Scientific Review Officer, EMNR IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6182
MSC 7892, Bethesda, MD 20892, 301 435–
2514, riverase@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: AIDS and AIDS Related Research.
Date: April 6, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
Bethesda, MD 20892, 301–451–8754, tuoj@
nei.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 12, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–05308 Filed 3–15–18; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
11763
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Responsibility of Applicants
for Promoting Objectivity in Research
for Which Public Health Service (PHS)
Funding Is Sought and Responsible
Prospective Contractors, Office of
Policy for Extramural Research
Administration (OPERA), Office of
Extramural Research (OER), Office of
the Director, (OD)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health, Office of
Policy and Extramural Research
Administration (OPERA), Office of
Extramural Research (OER), Office of
the Director (OD) will publish periodic
summaries of propose projects to be
submitted to the Office of Management
and Budget (OMB) for review and
approval.
SUMMARY:
Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
DATES:
To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Kathy Hancock, Asst. Grants
Compliance Officer, Division of Grants
Compliance and Oversight, Office of
Policy for Extramural Research
Administration, 6705 Rockledge Drive,
Suite 350, Bethesda, Maryland 20892 or
call non-toll-free number 301–435–0949
or Email your request to
FCOICompliance@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
FOR FURTHER INFORMATION CONTACT:
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\16MRN1.SGM
16MRN1
11764
Federal Register / Vol. 83, No. 52 / Friday, March 16, 2018 / Notices
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Proposed Collection Title:
Responsibility of Applicants for
Promoting Objectivity in Research for
which Public Health Service (PHS)
Funding is Sought 45 CFR part 50
Research for which PHS Funding is
Sought (42 CFR part 50, subpart F) and
Responsible Prospective Contractors (45
CFR part 94). The purpose of these
regulations is to promote objectivity in
research by requiring institutions to
establish standards to ensure that there
is no reasonable expectation that the
design, conduct, or reporting of PHSfunded research will be biased by any
Investigator financial conflict of interest
(FCOI).
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
677,295.
Subpart F and Responsible Prospective
Contractors 45 CFR part 94, 0925–
0417,—REINSTATEMENT WITHOUT
CHANGE Office of Policy and
Extramural Research Administration
(OPERA) Office of Extramural Research
(OER), Office of the Director (OD),
National Institutes of Health (NIH).
Need and Use of Information
Collection:
This request is for Office of
Management and Budget (OMB)
approval of a Reinstatement without
change of a currently approved
collection resulting from the
development of revised regulations
regarding the Responsibility of
Applicants for Promoting Objectivity in
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents based on applicable
section of regulation
daltland on DSKBBV9HB2PROD with NOTICES
Reporting:
Initial
Reports
under
42
CFR
50.605(b)(1) and (b)(3) or 45 CFR
94.5(b)(1) and (b)(3) from awardee Institutions.
Subsequent Reports under 42 CFR
50.605(a)(3)(iii) and (b)(2) or 45 CFR
94.5(a)(3)(iii) and (b)(2) from awardee
Institutions.
Annual
Report
under
42
CFR
50.605(b)(4) or 45 CFR 94.5(b)(4)
from awardee Institutions.
Subsequent Reports under 42 CFR
50.606(a) or 45 CFR 94.6 from awardee Institutions.
Record Keeping:
Under 42 CFR 50.604(i) or 45 CFR
94.4(i) from awardee institutions.
Disclosure:
Under 42 CFR 50.604(a) or 45 CFR 94.4
for Investigators.
Under 42 CFR 50.604(b) or 45 CFR
94.4(e)(1) for Investigators.
Under 42 CFR 50.604(b) or 45 CFR
94.4(e)(1) for Institutions.
Under 42 CFR 50.604(c)(1) or 45 CFR
94.4(c)(1) from subrecipients.
Under 42 CFR 50.604(d) or 45 CFR 94.4
for Institutions.
Under 42 CFR 50.604(e)(1) or 45 CFR
94.4(e)(1) for Investigators.
Under 42 CFR 50.604(e)(2) or 45 CFR
94.4(e)(2) for Investigators.
Under 42 CFR 50.604(e)(3) or 45 CFR
94.4(e)(3) for Investigators.
Under 42 CFR 50.604(f) or 45 CFR
94.4(f) for institutions 1.
Under 42 CFR 50.605(a)(1) or 45 CFR
94.5(a)(1) for Institutions.
Under 42 CFR 50.605(a)(3) or 45 CFR
94.5(a)(3) for Institutions.
Under 42 CFR 50.605(a)(3)(i) or 45 CFR
94.5(a)(3)(i).
Under 42 CFR 50.605(a)(3)(ii) or 45 CFR
94.5(a)(3)(ii).
Under 42 CFR 50.605(a)(3)(iii) or 45
CFR 94.5(a)(3)(iii).
VerDate Sep<11>2014
21:54 Mar 15, 2018
Jkt 244001
Frequency of
responses
Number of respondents
Average time
per response
(in hours)
Total annual
burden hour
992 .................................................................
1
2
1,984
50 FCOI reports as in 42 CFR
50.605(a)(3)(ii) and 45 CFR 94.5(a)(3)(ii).
1
2
100
5 mitigation reports ........................................
2,031 ..............................................................
1
1
2
1
10
2,031
20 ...................................................................
1
10
200
2,000 ..............................................................
1
4
8,000
3,000 ..............................................................
1
81
243,000
38,000 ............................................................
1
30/60
19,000
2,000 ..............................................................
1
6
12,000
500 .................................................................
1
1
500
3,000 4 ............................................................
1
1
3,000
38,000 ............................................................
1
4
152,000
38,000 ............................................................
1
1
38,000
950 .................................................................
1
30/60
475
2,000 ..............................................................
1
1
2,000
2,000 5 ............................................................
1
82
164,000
500 6 ...............................................................
1
3
1,500
50 7 .................................................................
1
80
4,000
50 8 .................................................................
1
80
4,000
50 ...................................................................
1
1
50
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
E:\FR\FM\16MRN1.SGM
16MRN1
11765
Federal Register / Vol. 83, No. 52 / Friday, March 16, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents based on applicable
section of regulation
Average time
per response
(in hours)
Frequency of
responses
Number of respondents
Total annual
burden hour
Under 42 CFR 50.605(a)(4) or 45 CFR
94.5(a)(4).
Public Website Posting under 42 CFR
50.605(a)(5) or 45 CFR 94.5(a)(5)
from awardee Institutions.
Under 42 CFR 50.606(c) or 45 CFR
94.6(c).
950 .................................................................
1
12
11,400
2,000 ..............................................................
1
5
10,000
50 9 .................................................................
3 10
18/60
45
Total ..................................................
136,143 ..........................................................
136,243
........................
677,295
4 Assuming
that 3,000 Institutions solicit disclosures on an annual basis by sending a notification to all Investigators.
an estimated 950 reports of Conflict of Interest are expected annually, the 2,000 responding Institutions must review all financial disclosures associated with PHS-funded awards to determine whether any conflicts of interest exist. Thus, the review burden of 76,000 hours is
based upon estimates that it will take on the average 2 hours for an institutional official(s) to review each of 38,000 financial disclosures associated with PHS funded awards. The burden for developing a management plan for identified FCOI is estimated at 80 hours × 950 cases = 76,000
hours.
6 Assuming that this is a rare occurrence based on prior experience.
7 Assuming only a fraction of the newly identified SFIs will constitute FCOI.
8 Assuming only a fraction of the newly identified SFIs will constitute FCOI.
9 Number based on 50.605/94.5(a)(3)(i)—of those only a fraction will relate to a project of clinical research whose purpose is to evaluate the
safety or effectiveness of a drug, medical device, or treatment, but we are calculating the maximum estimated burden.
10 Assuming an average of 3 publications annually.
5 Although
Dated: March 10, 2018.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2018–05384 Filed 3–15–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
daltland on DSKBBV9HB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: BTSS and SAT.
Date: March 26, 2018.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Guo Feng Xu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
VerDate Sep<11>2014
21:54 Mar 15, 2018
Jkt 244001
Health, 6701 Rockledge Drive, Room 5122,
MSC 7854, Bethesda, MD 20892, 301–237–
9870, xuguofen@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–17–
086/7: Tobacco Use and HIV in Low and
Middle-Income Countries.
Date: March 28, 2018.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Mark P. Rubert, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1775, rubertm@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 12, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–05307 Filed 3–15–18; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive Patent
License: Magnetic Resonance Imaging
System and Method for the
Measurement of Geometric Features of
Axons (Including Without Limitation
Diameter, Radius, Perimeter, Volume,
Surface and Angle) for the
Characterization and Diagnosis of
Central Nervous System Diseases and
Disorders
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Eunice Kennedy Shriver
National Institute for Child Health and
Human Development (NICHD), an
institute of the National Institutes of
Health, Department of Health and
Human Services, is contemplating the
grant of an Exclusive Patent License to
Brainvivo Ltd. (Brainvivo), located in
Tel Aviv, Israel, to practice the
inventions embodied in the patent
applications listed in the
Supplementary Information section of
this notice.
DATES: Only written comments and/or
complete applications for a license
which are received by the NCI
Technology Transfer Center on or before
April 2, 2018 will be considered.
ADDRESSES: Requests for copies of the
patent applications, inquiries, and
comments relating to the contemplated
Exclusive Patent License should be
directed to: Surekha Vathyam, Ph.D.,
SUMMARY:
E:\FR\FM\16MRN1.SGM
16MRN1
Agencies
[Federal Register Volume 83, Number 52 (Friday, March 16, 2018)]
[Notices]
[Pages 11763-11765]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05384]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Responsibility of
Applicants for Promoting Objectivity in Research for Which Public
Health Service (PHS) Funding Is Sought and Responsible Prospective
Contractors, Office of Policy for Extramural Research Administration
(OPERA), Office of Extramural Research (OER), Office of the Director,
(OD)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 to provide opportunity for public comment on proposed data
collection projects, the National Institutes of Health, Office of
Policy and Extramural Research Administration (OPERA), Office of
Extramural Research (OER), Office of the Director (OD) will publish
periodic summaries of propose projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact: Kathy
Hancock, Asst. Grants Compliance Officer, Division of Grants Compliance
and Oversight, Office of Policy for Extramural Research Administration,
6705 Rockledge Drive, Suite 350, Bethesda, Maryland 20892 or call non-
toll-free number 301-435-0949 or Email your request to
[email protected]. Formal requests for additional plans and
instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: Written comments and/or suggestions
from the public and affected agencies are invited to address one or
more of the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) The accuracy of the
[[Page 11764]]
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) Ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) Ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
Proposed Collection Title: Responsibility of Applicants for
Promoting Objectivity in Research for which Public Health Service (PHS)
Funding is Sought 45 CFR part 50 Subpart F and Responsible Prospective
Contractors 45 CFR part 94, 0925-0417,--REINSTATEMENT WITHOUT CHANGE
Office of Policy and Extramural Research Administration (OPERA) Office
of Extramural Research (OER), Office of the Director (OD), National
Institutes of Health (NIH).
Need and Use of Information Collection:
This request is for Office of Management and Budget (OMB) approval
of a Reinstatement without change of a currently approved collection
resulting from the development of revised regulations regarding the
Responsibility of Applicants for Promoting Objectivity in Research for
which PHS Funding is Sought (42 CFR part 50, subpart F) and Responsible
Prospective Contractors (45 CFR part 94). The purpose of these
regulations is to promote objectivity in research by requiring
institutions to establish standards to ensure that there is no
reasonable expectation that the design, conduct, or reporting of PHS-
funded research will be biased by any Investigator financial conflict
of interest (FCOI).
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 677,295.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average time
Type of respondents based on Number of respondents Frequency of per response Total annual
applicable section of regulation responses (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Reporting:
Initial Reports under 42 CFR 992........................ 1 2 1,984
50.605(b)(1) and (b)(3) or 45
CFR 94.5(b)(1) and (b)(3) from
awardee Institutions.
Subsequent Reports under 42 CFR 50 FCOI reports as in 42 1 2 100
50.605(a)(3)(iii) and (b)(2) CFR 50.605(a)(3)(ii) and
or 45 CFR 94.5(a)(3)(iii) and 45 CFR 94.5(a)(3)(ii).
(b)(2) from awardee
Institutions.
5 mitigation reports....... 1 2 10
Annual Report under 42 CFR 2,031...................... 1 1 2,031
50.605(b)(4) or 45 CFR
94.5(b)(4) from awardee
Institutions.
Subsequent Reports under 42 CFR 20......................... 1 10 200
50.606(a) or 45 CFR 94.6 from
awardee Institutions.
Record Keeping:
Under 42 CFR 50.604(i) or 45 2,000...................... 1 4 8,000
CFR 94.4(i) from awardee
institutions.
Disclosure:
Under 42 CFR 50.604(a) or 45 3,000...................... 1 81 243,000
CFR 94.4 for Investigators.
Under 42 CFR 50.604(b) or 45 38,000..................... 1 30/60 19,000
CFR 94.4(e)(1) for
Investigators.
Under 42 CFR 50.604(b) or 45 2,000...................... 1 6 12,000
CFR 94.4(e)(1) for
Institutions.
Under 42 CFR 50.604(c)(1) or 45 500........................ 1 1 500
CFR 94.4(c)(1) from
subrecipients.
Under 42 CFR 50.604(d) or 45 3,000 \4\.................. 1 1 3,000
CFR 94.4 for Institutions.
Under 42 CFR 50.604(e)(1) or 45 38,000..................... 1 4 152,000
CFR 94.4(e)(1) for
Investigators.
Under 42 CFR 50.604(e)(2) or 45 38,000..................... 1 1 38,000
CFR 94.4(e)(2) for
Investigators.
Under 42 CFR 50.604(e)(3) or 45 950........................ 1 30/60 475
CFR 94.4(e)(3) for
Investigators.
Under 42 CFR 50.604(f) or 45 2,000...................... 1 1 2,000
CFR 94.4(f) for institutions
\1\.
Under 42 CFR 50.605(a)(1) or 45 2,000 \5\.................. 1 82 164,000
CFR 94.5(a)(1) for
Institutions.
Under 42 CFR 50.605(a)(3) or 45 500 \6\.................... 1 3 1,500
CFR 94.5(a)(3) for
Institutions.
Under 42 CFR 50.605(a)(3)(i) or 50 \7\..................... 1 80 4,000
45 CFR 94.5(a)(3)(i).
Under 42 CFR 50.605(a)(3)(ii) 50 \8\..................... 1 80 4,000
or 45 CFR 94.5(a)(3)(ii).
Under 42 CFR 50.605(a)(3)(iii) 50......................... 1 1 50
or 45 CFR 94.5(a)(3)(iii).
[[Page 11765]]
Under 42 CFR 50.605(a)(4) or 45 950........................ 1 12 11,400
CFR 94.5(a)(4).
Public Website Posting under 42 2,000...................... 1 5 10,000
CFR 50.605(a)(5) or 45 CFR
94.5(a)(5) from awardee
Institutions.
Under 42 CFR 50.606(c) or 45 50 \9\..................... 3 \10\ 18/60 45
CFR 94.6(c).
----------------------------------------------------------------------------
Total...................... 136,143.................... 136,243 .............. 677,295
----------------------------------------------------------------------------------------------------------------
\4\ Assuming that 3,000 Institutions solicit disclosures on an annual basis by sending a notification to all
Investigators.
\5\ Although an estimated 950 reports of Conflict of Interest are expected annually, the 2,000 responding
Institutions must review all financial disclosures associated with PHS-funded awards to determine whether any
conflicts of interest exist. Thus, the review burden of 76,000 hours is based upon estimates that it will take
on the average 2 hours for an institutional official(s) to review each of 38,000 financial disclosures
associated with PHS funded awards. The burden for developing a management plan for identified FCOI is
estimated at 80 hours x 950 cases = 76,000 hours.
\6\ Assuming that this is a rare occurrence based on prior experience.
\7\ Assuming only a fraction of the newly identified SFIs will constitute FCOI.
\8\ Assuming only a fraction of the newly identified SFIs will constitute FCOI.
\9\ Number based on 50.605/94.5(a)(3)(i)--of those only a fraction will relate to a project of clinical research
whose purpose is to evaluate the safety or effectiveness of a drug, medical device, or treatment, but we are
calculating the maximum estimated burden.
\10\ Assuming an average of 3 publications annually.
Dated: March 10, 2018.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2018-05384 Filed 3-15-18; 8:45 am]
BILLING CODE 4140-01-P